-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Monopar Therapeutics, Raises Price Target to $133

Benzinga·08/12/2026 19:48:45
Listen to the news
BTIG analyst Jeet Mukherjee maintains Monopar Therapeutics (NASDAQ:MNPR) with a Buy and raises the price target from $117 to $133.